| | | | | | | |
 | JOHNSON & JOHNSON | 0.42% | 0.98% | 4.48% | 13.07% | 30.13% | 465 378 |
| ABBVIE INC. | 0.28% | 1.41% | 19.37% | 39.44% | 85.72% | 284 947 |
| PFIZER, INC. | 1.90% | 4.56% | -13.50% | -6.58% | 33.40% | 281 395 |
| MERCK & CO., INC. | -0.29% | 2.79% | 43.27% | 47.50% | 26.15% | 279 198 |
 | NOVO NORDISK A/S | -0.31% | 5.88% | 21.06% | 24.95% | 135.96% | 277 043 |
 | ROCHE HOLDING AG | -0.79% | 0.47% | -18.87% | -15.92% | 1.37% | 267 529 |
 | ASTRAZENECA PLC | -0.55% | 2.53% | 28.35% | 33.97% | 50.07% | 206 469 |
| NOVARTIS AG | -0.63% | 2.42% | 4.10% | 12.57% | -7.56% | 189 396 |
| BRISTOL-MYERS SQUIBB COMPANY | 0.75% | 1.44% | 29.72% | 47.19% | 40.88% | 178 193 |
| AMGEN INC. | -0.16% | 0.90% | 27.10% | 42.40% | 22.47% | 152 817 |
 | SANOFI | -1.49% | 0.52% | -2.74% | 0.36% | 4.40% | 111 840 |
| GILEAD SCIENCES, INC. | 0.08% | 2.90% | 21.06% | 27.52% | 32.94% | 110 160 |
| GSK PLC | 0.47% | 2.57% | -29.19% | -26.19% | -34.27% | 67 963 |
 | DAIICHI SANKYO CO., LTD. | -4.18% | -0.91% | 50.60% | 55.41% | 88.46% | 62 153 |
 | BAYER AG | -0.38% | -0.86% | 16.64% | 20.83% | -18.86% | 56 107 |
| | | | | | | |
| | Gemiddelde | -0.33% | 1.84% | 13.43% | 21.10% | 32.75% | |
| | Gewogen gemiddelde per kap. | -0.03% | 2.17% | 12.32% | 20.59% | 39.80% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
